Literature DB >> 15786896

Tuberculin skin test: estimation of positive and negative predictive values from routine data.

G M Berkel1, F G J Cobelens, G de Vries, I W E Draayer-Jansen, M W Borgdorff.   

Abstract

OBJECTIVE: To estimate, using routinely available data, the predictive values of tuberculin testing with 2TU RT23 for detection of latent tuberculosis infection (LTBI) in the Dutch population as a basis for recommendations on cut-off values at various levels of infection prevalence.
DESIGN: Smoothed distributions of TST reactions among 312 tuberculosis patients and 2848 healthy non-BCG-vaccinated persons were used to estimate the sensitivity and specificity at various cut-off values.
RESULTS: Sensitivity was 98.9% at 5 mm, 95.4% at 10 mm and 79.8% at 15 mm cut-off. Specificity with the corresponding cut-offs was 95.3%, 96.3% and 97.1% before and 98.0%, 98.8% and 99.6% after adjustment for presumed LTBI. At 10 mm, the positive predictive value (PPV) was > 75% if the infection prevalence in the tested population was at least 10%, but strongly declined with lower prevalences. For lower prevalences a cut-off of 15 mm was proposed, as this results in a higher PPV without greatly affecting the negative predictive value.
CONCLUSION: Estimation of the predictive values of the TST from routine data can be useful for establishing cut-off values for detection of LTBI in different populations with different tuberculin preparations.

Entities:  

Mesh:

Year:  2005        PMID: 15786896

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

Authors:  Benjamin L Laskin; Jens Goebel; Jeffrey R Starke; Daniel P Schauer; Mark H Eckman
Journal:  Am J Kidney Dis       Date:  2012-07-10       Impact factor: 8.860

2.  Tuberculosis Screening in Silica-Exposed Workers : Developing a Tool for Health Care Providers.

Authors:  Nicholas K Reul; Zachary Gray; Barbara Burchell Braid; Margaret A Leland
Journal:  Public Health Rep       Date:  2021-09-09       Impact factor: 2.792

3.  Does BCG vaccination protect against infection with M. tuberculosis?

Authors:  P T Pelzer; Y Smit; E W Tiemersma; N T Huong; N V Nhung; F Cobelens
Journal:  Int J Tuberc Lung Dis       Date:  2022-06-01       Impact factor: 3.427

4.  Appraisal of interpretation criteria for the comparative intradermal tuberculin test for diagnosis of tuberculosis in cattle in central Ethiopia.

Authors:  Gobena Ameni; Glyn Hewinson; Abraham Aseffa; Douglas Young; Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2008-05-21

5.  The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials.

Authors:  Ibrahim Abubakar; Frank G J Cobelens; Molebogeng X Rangaka
Journal:  Am J Respir Crit Care Med       Date:  2020-03-01       Impact factor: 21.405

6.  Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts.

Authors:  Mustafa Bakir; Davinder P S Dosanjh; Jonathan J Deeks; Ahmet Soysal; Kerry A Millington; Serpil Efe; Yasemin Aslan; Dilek Polat; Nihat Kodalli; Aysegul Yagci; Isil Barlan; Nerin Bahceciler; Emel E Demiralp; Ajit Lalvani
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

7.  School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.

Authors:  Brita Askeland Winje; Fredrik Oftung; Gro Ellen Korsvold; Turid Mannsåker; Ingvild Nesthus Ly; Ingunn Harstad; Anne Margarita Dyrhol-Riise; Einar Heldal
Journal:  BMC Infect Dis       Date:  2008-10-17       Impact factor: 3.090

8.  Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test.

Authors:  Brita Askeland Winje; Fredrik Oftung; Gro Ellen Korsvold; Turid Mannsåker; Anette Skistad Jeppesen; Ingunn Harstad; Berit Tafjord Heier; Einar Heldal
Journal:  BMC Infect Dis       Date:  2008-05-14       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.